Prognostic significance of p16 expression in high‐grade prostate adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic significance of p16 expression in high‐grade prostate adenocarcinoma

Published:2020-08-09 Issue:10 Volume:70 Page:743-751
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathology International

Author:

Takahara Taishi¹^ORCID,Satou Akira¹^ORCID,Sugie Miho²,Watanabe Masahito³,Kanao Kent⁴,Sumitomo Makoto⁵,Tsuzuki Toyonori¹^ORCID

Affiliation:

1. Department of Surgical Pathology Aichi Medical University Hospital Aichi Japan

2. Department of Urology Minato Medical Coop‐Kyoritsu General Hospital Tokyo Japan

3. Department of Urology Aichi Medical University Hospital Aichi Japan

4. Department of Uro‐oncology Saitama Medical University International Medical Center Saitama Japan

5. Department of Urology Fujita Health University Aichi Japan

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pin.12997

Reference43 articles.

1. WHOclassification of tumours of the urinary system and male genital organs. 4th edn.International agency for reserch on cancer.2016.

2. Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm

3. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

4. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

5. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p16 Immunohistochemical Expression in Nephrogenic Adenoma;Cureus;2023-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3